← Back
other
CAR-T cell therapy
Last discussed Oct 19, 2026
A type of cancer immunotherapy where a patient's T cells are genetically modified to better attack cancer cells.
Recently discussed in
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Siddhartha Mukherjee · Oct 19, 2026
How #medicine could change in the next 25 years
Siddhartha Mukherjee · Mar 8, 2026
What creators say
SM
Siddhartha Mukherjee
mentioned
Used for: Treating B cell leukemias and lymphomas
Praised: Durable cures; patients 15+ years post-therapy
vs: Struggles in solid tumors because it is lineage-specific rather than cancer-s...
"This has been a great success in leukemias, B cell leukemias and B cell lymphomas, producing not just small cures, but durable cures. Just as a plug for one of the things I do, I created one of the first CAR-T cell companies in India, where we sel..."
More from Siddhartha Mukherjee →+1 more mention from Siddhartha
"One of my companies made the first CAR-T cells in India. They cost $600,000 in the United States. So we're selling them for $40,000 in India."
How #medicine could change in the next 25 years
· Mar 8, 2026
Keep exploring
Topics
About this data
- ✓45,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it